7:00 am - 6:00 pm
7:00 am - 7:30 am
7:30 am - 8:45 am
Reducing the Overall Risk of Cardiovascular Morbidity and Mortality in the CKD Population
Supported by an educational grant from Sanofi Renal
Orlando M. Gutierrez, MD, MMSc
- Analyze the laboratory values that can impact the development of hypercalcemia, hyperlipidemia and systemic inflammatory markers in the CKD patient.
- Discuss the risk factors that can impact the development of hypercalcemia, hyperlipidemia and systemic inflammatory markers in the CKD patient.
- Recognize effective treatment strategies to minimize hypercalcemia, hyperlipidemia and systemic inflammatory markers in the individual with CKD or incident to hemodialysis/peritoneal dialysis.
8:45 am - 9:45 am
Exhibits Open / Coffee Break
10:00 am - 11:30 am
Concurrent Sessions (111-114)
It Starts with a Spark
Kristin Larson, MSN, RN, ANP, GNP, CNN
- Compare and contrast the concepts of precepting, orienting, and mentoring.
- Incorporate generational characteristics and outline mentoring strategies for nurses of all age groups.
- Through case studies, outline a mentoring plan for nephrology nurses new to practice and seasoned in practice.
You Take My Breath Away
Judy Kauffman, MSN, RN, CNN
Mary Perrecone, MS, RN, CCRN, CNN
- Define hypoxia and the physiologic responses to hypoxia.
- Discuss causes and effects of hypoxia in the person with CKD.
- Compare and contrast various techniques for measuring hypoxia.
- Describe strategies to prevent and treat hypoxia.
Blurred Lines: Primary Care in Dialysis
Lisa Koester, MSN, ANP, CNN-NP
- Describe the role of the nephrology APN in providing primary care.
- Discuss the challenges to providing primary care for dialysis patients.
- Explore the pros and cons of providing primary care for dialysis patients.
Should Kids Go to the Front of the Line: Controversies in Transplant
Kenneth Andreoni, MD
- Analyze the ethical implications of a recent case study involving a pediatric lung transplant.
- Explain the current organ allocation policy related to the prioritization of the pediatric transplant candidate.
- Explore the impact of the proposed changes in kidney transplant allocation policies.
11:30 am - 12:30 pm
Exhibits Open / Coffee Break
12:45 pm - 1:15 pm
1:15 pm - 2:30 pm
Biosimilar Medications: What Nephrology APNs and Nurses Need to Know
Supported by an educational donation from Amgen
Tracy Anderson-Haag, PharmD, BCPS
- Discuss the origins of biopharmaceutical and biosimilar medications.
- Examine the technology that has led to the development of biosimilars in immunologic therapies and in anemia management.
- Review the important differences between generic medications and biosimilar agents.
- Discuss strategies that can be implemented to successfully improve patient safety when utilizing biosimilar agents.
2:45 pm - 4:15 pm
Concurrent Sessions (131-134)
Recognizing and Rewarding Excellence in YOUR Setting
Mary Robinson, PhD, RN, NEA-BC
- Discuss the initial research and the outcomes (relevance) of the Magnet approach/perspective to outpatient settings.
- Identify the "attractive" positive effects of implementing Magnet concepts in the work setting.
- Determine how to implement a nursing excellence program in a dialysis patient care setting.
Fred Is Missing: Dealing with Death in the Dialysis Unit
Mary Haras, PhD, MS, MBA, APN, NP-C, CNN
- Assess the impact of grief and loss on patients and staff.
- Develop strategies to support healthy methods of grieving among individuals affected by the loss.
- Discuss ways to allow expressions of grief that maintain professional behavior.
Osteoporosis in CKD
Ann Hallock, DNP, APRN, CNP, CNN
- Identify the pathophysiologic changes seen in osteoporosis.
- Discuss the pharmacologic therapies for the treatment of osteoporosis.
- Determine the implications of the management of osteoporosis as the glomerular filtration rate declines.
Confusion on Transfusion
Debbie Ashton, BSN, RN, CNN
- Identify the indications for transfusion in the individualwith CKD.
- Describe the potential complications of a transfusion.
- Discuss best practices in the administration of transfusions in the individual with CKD.
4:30 pm - 6:00 pm
Concurrent Sessions (141-144)
Financial Exploitation in ESRD
Lisa Zokas Kindy, JD
- Describe situations of financial exploitation.
- Identify signs of possible financial exploitation.
- Examine the nurse's legal responsibilities in addressing suspected incidences of financial exploitation.
Is There an App for That? Renal Applications
LaTricia Perry, MSN, RN
- Analyze how access to information has changed with the use of portable devices.
- Explore software applications for portable devices useful for nephrology practice.
- Describe the inclusion of the patient perspective on the use of software applications.
- Appraise the validity of the content of software applications.
Peri, Endo, and Myocarditis: Knowing the Cardiac "itis"
Paul St. Laurent, DNP, RN, ACNP-BC, CCRN-CMC
- Discuss the etiology of endocarditis, pericarditis, and myocarditis in individuals with CKD.
- Analyze assessment and diagnostic study findings that differentiate among endocarditis, pericarditis, and myocarditis.
- Select treatment strategies for cardiac inflammation and infection.
Hypercholesterolemia / Lipid Apheresis
Lynne Braun, PhD, CNP, FAHA
- Discuss the pathophysiology of hypercholesterolemia.
- Review the disorders that contribute to hypercholesterolemia.
- Identify treatment strategies to lower cholesterol.
- Modify treatment of hypercholesterolemia based upon CKD stage or treatment modality.